Clinical trial
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
NCT05714059
Study timeline
Study start (actual)2023-02-28Date precision: day
Registry last updated2025-02-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetesunresolved
Interventions
Sponsors & collaborators
Medtronic MiniMed, Inc.lead sponsor
Mapped research locations
BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1AtlantaGeorgia, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1ClevelandOhio, United States1TampaFlorida, United States1AuroraColorado, United States1New HavenConnecticut, United States1Little RockArkansas, United States1TacomaWashington, United States1Palo AltoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05714059 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.